Latest AI and machine learning research in liver transplantation for healthcare professionals.
Hepatitis B virus (HBV) infection remains a leading cause of cirrhosis and hepatocellular carcinoma worldwide, and long-term control relies on sustained immunization and effective reduction of transmission. In high-burden settings, vaccination programs have expanded substantially, but there still exist differences in the immune response effect after vaccination and the phenomenon of post-vaccinati...
PURPOSE OF REVIEW: Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, producing durable responses across multiple malignancies. However, treatment outcomes may be influenced by immunological drug-drug interactions (DDIs) arising from commonly prescribed concomitant medications. Unlike classical pharmacokinetic or pharmacodynamic DDIs, these interactions operate through systemic m...
BACKGROUND: Reactive oxygen species (ROS) are critical regulators of tumor development and progression, yet their clinical significance and cellular m...
The early diagnosis of hepatocellular carcinoma (HCC) lacks biomarkers with a high sensitivity and specificity. This study was to find sensitive and s...
BACKGROUND: The transfusion of blood components remains a cornerstone in the management of hematological and onco-hematological diseases. Effective bl...
Emerging evidence highlights hypoxia-responsive long non-coding RNAs (lncRNAs) as potential modulators in tumor biology. In this study, we explored th...
BACKGROUND: Given the interplay of cirrhosis with malignancy, management of hepatocellular carcinoma (HCC) relies on multidisciplinary clinician judge...
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking effective targeted therapies. Although immune checkpoint inhibitors such as pemb...
BACKGROUND: The prognosis for patients with glioblastoma (GBM) remains extremely poor, a challenge largely attributable to the complex nature of its m...
BACKGROUND: Testing for Blood-Borne-Viruses (BBVs) such as the human immunodeficiency virus (HIV), hepatitis C virus (HCV) and hepatitis B virus (HBV)...
BACKGROUND: Definitive chemoradiotherapy for head and neck squamous cell carcinomas (HNSCC) carries significant long-term toxicities, with elective ne...
BACKGROUND: Sepsis is a major global health challenge characterized by a complex pathogenesis involving an early hyperinflammatory phase followed by a...
BACKGROUND: Telomeres, located at chromosome ends, regulate cell division and maintain genomic stability. Telomere-related genes (TRGs) play essential...
BACKGROUND: Cirrhosis and sarcopenia frequently coexist and are associated with poor clinical outcomes; however, their shared genetic basis remains in...
Chronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD) frequently coexist, and lipid metabolic dysregulation may represent a shared b...
Glioblastoma (GBM), the most aggressive primary brain tumor, develops within a tumor microenvironment (TME) dominated by tumor-associated macrophages ...
BACKGROUND: Lung squamous cell carcinoma (LUSC) exhibits poor prognosis and a highly complex tumor immune microenvironment (TIME), creating an urgent ...
RNA-based cancer immunotherapy has emerged as a next-generation strategy in oncology, harnessing the versatile properties of RNA molecules to activate...
BACKGROUND: Liver cirrhosis (LC) is a chronic liver disease with global prevalence. Current diagnostic methods for LC still face limitations in safety...
Hypoxia is pervasive within the solid tumor microenvironment (TME), reshaping it through exosome release. As the main component of the tumor stroma, f...